ENTRY       D02910                      Drug
NAME        Amiodarone (USAN/INN)
FORMULA     C25H29I2NO3
EXACT_MASS  645.0237
MOL_WEIGHT  645.3116
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
              DG01455  beta-Adrenergic receptor agonist
               DG01451  beta1-Adrenergic receptor agonist
             DG01653  Antiarrhythmics
              DG01648  Class III antiarrhythmic agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C06823
            ATC code: C01BD01
            Chemical structure group: DG00204
            Product (DG00204): D00636<JP/US>
EFFICACY    Antiarrhythmic, Potassium channel blocker
TARGET      KCND3 [HSA:3752] [KO:K04893]
            KCNH2 [HSA:3757] [KO:K04905]
            KCNQ1 [HSA:3784] [KO:K04926]
            KCNJ3 [HSA:3760] [KO:K04997]
            KCNJ5 [HSA:3762] [KO:K04999]
            KCNJ8 [HSA:3764] [KO:K05001]
            KCNJ11 [HSA:3767] [KO:K05004]
            KCNJ12 [HSA:3768] [KO:K05005]
            ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
            ADRB1 [HSA:153] [KO:K04141]
            SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04020(146+147+148+153)  Calcium signaling pathway
            hsa04022(146+147+148+153+3764)  cGMP-PKG signaling pathway
            hsa04024(153)  cAMP signaling pathway
            hsa04080(146+147+148+153)  Neuroactive ligand-receptor interaction
            hsa04261(146+147+148+153+3784+6331)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07037  Antiarrhythmic drugs
            map07231  Sodium channel blocking drugs
            map07232  Potassium channel blocking and opening drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BD Antiarrhythmics, class III
                 C01BD01 Amiodarone
                  D02910  Amiodarone (USAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01455  beta-Adrenergic receptor agonist
                DG01451  beta1-Adrenergic receptor agonist
                 DG00204  Amiodarone
                  D02910  Amiodarone
              DG01653  Antiarrhythmics
               DG01648  Class III antiarrhythmic agent
                DG00204  Amiodarone
                 D02910  Amiodarone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00204  Amiodarone
                 D02910  Amiodarone
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D02910  Amiodarone (USAN/INN)
                ADRB1
                 D02910  Amiodarone (USAN/INN)
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D02910  Amiodarone (USAN/INN)
                SCN2A
                 D02910  Amiodarone (USAN/INN)
                SCN3A
                 D02910  Amiodarone (USAN/INN)
                SCN4A
                 D02910  Amiodarone (USAN/INN)
                SCN5A
                 D02910  Amiodarone (USAN/INN)
                SCN8A
                 D02910  Amiodarone (USAN/INN)
                SCN9A
                 D02910  Amiodarone (USAN/INN)
                SCN10A
                 D02910  Amiodarone (USAN/INN)
                SCN11A
                 D02910  Amiodarone (USAN/INN)
               Potassium channels
                KCND3
                 D02910  Amiodarone (USAN/INN)
                KCNH2
                 D02910  Amiodarone (USAN/INN)
                KCNQ1
                 D02910  Amiodarone (USAN/INN)
               Inward rectifier channels (Kir)
                KCNJ3
                 D02910  Amiodarone (USAN/INN)
                KCNJ5
                 D02910  Amiodarone (USAN/INN)
                KCNJ8
                 D02910  Amiodarone (USAN/INN)
                KCNJ11
                 D02910  Amiodarone (USAN/INN)
                KCNJ12
                 D02910  Amiodarone (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02910
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01455  beta-Adrenergic receptor agonist
                DG01451  beta1-Adrenergic receptor agonist
                 DG00204  Amiodarone
              DG01653  Antiarrhythmics
               DG01648  Class III antiarrhythmic agent
                DG00204  Amiodarone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00204  Amiodarone
DBLINKS     CAS: 1951-25-3
            PubChem: 17397067
            ChEBI: 2663
            PDB-CCD: BBI
            LigandBox: D02910
            NIKKAJI: J7.829H
ATOM        31
            1   C8x C    17.7800  -21.6300
            2   C8x C    17.7800  -23.0300
            3   C8x C    18.9700  -23.7300
            4   C8y C    20.2300  -23.0300
            5   C8y C    20.2300  -21.6300
            6   C8x C    18.9700  -20.8600
            7   O2x O    21.5600  -23.4500
            8   C8y C    22.4000  -22.3300
            9   C8y C    21.5600  -21.1400
            10  C5a C    21.5600  -19.7400
            11  C8y C    22.7500  -19.0400
            12  O5a O    20.3700  -19.0400
            13  C8x C    24.0100  -19.7400
            14  C8y C    25.2000  -19.0400
            15  C8y C    25.2000  -17.6400
            16  C8y C    24.0100  -16.9400
            17  C8x C    22.7500  -17.6400
            18  O2a O    26.4600  -16.9400
            19  X   I    26.4600  -19.7400
            20  X   I    24.0100  -15.5400
            21  C1b C    27.6500  -17.6400
            22  C1b C    28.8400  -16.9400
            23  N1c N    30.0300  -17.6400
            24  C1b C    31.2200  -16.9400
            25  C1b C    30.0300  -19.0400
            26  C1a C    31.2200  -19.7400
            27  C1a C    32.4100  -17.6400
            28  C1b C    23.7300  -22.3300
            29  C1b C    24.4300  -23.5200
            30  C1b C    25.8300  -23.5200
            31  C1a C    26.5300  -24.7100
BOND        33
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    5   9 1
            11    9  10 1
            12   10  11 1
            13   10  12 2
            14   11  13 2
            15   13  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   11  17 1
            20   15  18 1
            21   14  19 1
            22   16  20 1
            23   18  21 1
            24   21  22 1
            25   22  23 1
            26   23  24 1
            27   23  25 1
            28   25  26 1
            29   24  27 1
            30    8  28 1
            31   28  29 1
            32   29  30 1
            33   30  31 1
///
